<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F77D9A17-7642-4FC6-A269-02E87B59AB8A"><gtr:id>F77D9A17-7642-4FC6-A269-02E87B59AB8A</gtr:id><gtr:name>European Society of Clinical Microbiology and Infectious Diseases (ESCMID)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:department>Centre for Infection &amp; Immunity</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F77D9A17-7642-4FC6-A269-02E87B59AB8A"><gtr:id>F77D9A17-7642-4FC6-A269-02E87B59AB8A</gtr:id><gtr:name>European Society of Clinical Microbiology and Infectious Diseases (ESCMID)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/336D9931-159D-4E03-82A0-7D4B41D0B68E"><gtr:id>336D9931-159D-4E03-82A0-7D4B41D0B68E</gtr:id><gtr:firstName>Thamarai</gtr:firstName><gtr:surname>Schneiders</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601199"><gtr:id>7BC0D6D9-C467-4C2B-B34A-316EBF66D75F</gtr:id><gtr:title>The Role of the RamA Locus in the Establishment of Antibiotic Resistance and its Potential for Novel Antibiotic Therapy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601199</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Transcription factors that control pleiotrophic phenotypes in bacterial metabolism and physiology present a novel opportunity to inhibit microbes on several levels. As such, proteins that confer both an antibiotic resistant phenotype and promote virulence gene expression are particularly attractive drug targets. The RamA protein found in Klebsiella pneumoniae and Salmonella spp. is a transcription factor that plays a role in multidrug resistance and virulence. This project aims to understand the role of RamA in antibiotic resistance through its regulation and expression. The specific aims of the research project are to determine the regulation of the ramA gene and the genes it regulates; to investigate the prevalence of increased ramA gene expression and its contribution to the dissemination and emergence of clonal and non-clonal multidrug resistant populations of Klebsiella and Salmonella spp; and finally to understand the population dynamics of ramA expression in an antibiotic susceptible bacterial population. The study of the role of ramA in the emergence of antibiotic resistance is of critical importance, as unlike most other antibiotic resistance mechanisms, it is not drug specific but rather a response triggered by a host of unrelated compounds. Studying the function of this gene and its products is critical to the understanding of its role in antibiotic resistance, especially in bacteria that are multidrug resistant and which clearly pose a threat to human health.</gtr:technicalSummary><gtr:fund><gtr:end>2011-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>496072</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Society of Clinical Microbiology and Infectious Diseases (ESCMID)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>Small RNAs in mediating Antimicrobial resistance</gtr:description><gtr:id>4CA1B666-8502-4E0A-BFB0-F33D66495713</gtr:id><gtr:impact>Manuscript in Review.</gtr:impact><gtr:outcomeId>dRWV2EkDUkf-1</gtr:outcomeId><gtr:partnerContribution>Furthering the research findings and opening up a new area of research.</gtr:partnerContribution><gtr:piContribution>From the funding from the MRC, identified novel small RNAs that were upregualted as a result of RamA upregulation. Research that lead to this was performed by personnel funded on the MRC grant. As a result of this finding, I was awarded the ESCMID Young Investigator Research Grant.</gtr:piContribution><gtr:sector>Learned Society</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Antimicrobial Therapy</gtr:department><gtr:description>Dr Jan Chesham</gtr:description><gtr:id>413B1B17-50BD-44E2-9607-A783F515745B</gtr:id><gtr:impact>Manuscripts (4) published.

A second proposal to continue the work has been invited and submitted.</gtr:impact><gtr:outcomeId>cPH2VTdjfs5-1</gtr:outcomeId><gtr:partnerContribution>Further investigations into the intrinsic resistome of nosocomial pathogens-expanding research field.</gtr:partnerContribution><gtr:piContribution>Funded Proposal to study intrinsic mechanisms of antibiotic resistance in K. pneumoniae.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Visiting School Students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D9465B9C-9F2A-4C12-B589-79DA4C68F132</gtr:id><gtr:impact>2-3 students (as part of the Nufflied scheme) visited the laboratory as part of scheme within Northern Ireland for school students to see what lab work is like. The students participitated in simple lab activities and reviewed the findings of their research.

A four fold increase in the numbers recruited to the Microbiology Pathway at Queen's University.</gtr:impact><gtr:outcomeId>FKSV6VdgpEj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer Plc Investigator Initiated Grants</gtr:description><gtr:end>2013-04-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>CF7EBC44-9069-41AC-84A8-71EEBB111995</gtr:id><gtr:outcomeId>YfYik6FKdQ20</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Northern Ireland Research and Development Office Grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Public Health Agency (PHA)</gtr:fundingOrg><gtr:id>D3AAB728-4140-4F18-BDFB-1FD91371BEA7</gtr:id><gtr:outcomeId>hW76xpZSAxy</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ESCMID Young Investigator Awards</gtr:description><gtr:end>2012-02-02</gtr:end><gtr:fundingOrg>European Society of Clinical Microbiology and Infectious Diseases (ESCMID)</gtr:fundingOrg><gtr:id>2850D9A7-AE7D-4581-8DE6-C5F2A1D76F57</gtr:id><gtr:outcomeId>NB6FBQxPfmy0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>This strain has now been sequenced by the Wellcome Trust Sanger Centre and is based in a public repository for use. The strain is available for distribution for academic purposes under appropriate material transfer agreements with the University of Edinburgh.</gtr:description><gtr:id>734A58ED-5CA4-4376-B85D-EA036FDD4822</gtr:id><gtr:impact>This database is used to mine for sequences particularly in relation to creating strains bearing targeted genetic deletions that allow functional characterisation of different phenotypes.</gtr:impact><gtr:outcomeId>56e007b2195bb5.01223436</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Klebsiella pneumoniae Ecl8</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.sanger.ac.uk/science/groups/thomson-group</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Equipment purchase and setup of microarray equipment. We have used this infrastructure to generate data for work funded by the MRC and to further this work. This facility will be available for use by other researchers using custom-made arrays in 2010.</gtr:description><gtr:id>2A0D3922-EB84-4C7D-9E36-DE6281B5DB5E</gtr:id><gtr:impact>My group has used this technique to generate data that we have published.</gtr:impact><gtr:outcomeId>5339585B654</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Microarray/Genomics Facility</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Antibodies generated to study the RamA and RamR proteins funded by the MRC NIRG.</gtr:description><gtr:id>0478F931-A6CF-42DD-B583-6C1AD633799B</gtr:id><gtr:impact>These antibodies are being used by my group to generate data that is being prepared for publications. To our knowledge we are the first to do so. We have also given the antibodies to our collaborators to assess the levels of protein when plants/ animals are colonized with Klebsiella.</gtr:impact><gtr:outcomeId>6A8277B2A88</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Antibodies</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D762E4B9-D2FA-4E55-AB50-F8F0F95EDD16</gtr:id><gtr:title>Tigecycline resistance can occur independently of the ramA gene in Klebsiella pneumoniae.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec5bfacf2a5bbffc593b18052f79366c"><gtr:id>ec5bfacf2a5bbffc593b18052f79366c</gtr:id><gtr:otherNames>Veleba M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>pm_15726_26_22644034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44444D41-6F36-41BD-8F45-B7CCED325FBA</gtr:id><gtr:title>Genetic regulation of the ramA locus and its expression in clinical isolates of Klebsiella pneumoniae.</gtr:title><gtr:parentPublicationTitle>International journal of antimicrobial agents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/582a33e77f73e5f0375225bfd5c49acd"><gtr:id>582a33e77f73e5f0375225bfd5c49acd</gtr:id><gtr:otherNames>Rosenblum R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0924-8579</gtr:issn><gtr:outcomeId>6924E6D1_86924E6D1_8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59E165BA-C3B2-40F8-93F2-C3D7F4375D11</gtr:id><gtr:title>Molecular basis of non-mutational derepression of ramA in Klebsiella pneumoniae.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df3614991a03102db4929c8541ca62c1"><gtr:id>df3614991a03102db4929c8541ca62c1</gtr:id><gtr:otherNames>De Majumdar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>546293ed652e70.61950009</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82F3992E-E7F1-4057-97AF-5B8A16FD9E9C</gtr:id><gtr:title>Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec5bfacf2a5bbffc593b18052f79366c"><gtr:id>ec5bfacf2a5bbffc593b18052f79366c</gtr:id><gtr:otherNames>Veleba M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>pm_15726_26_22644028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3051F9F-415F-41DC-AD5F-3EFFF004EC75</gtr:id><gtr:title>Spread of carbapenem-resistant Acinetobacter baumannii carrying a plasmid with two genes encoding OXA-72 carbapenemase in Lithuanian hospitals.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fdd53c30973db86a8157472bb91a2ea"><gtr:id>2fdd53c30973db86a8157472bb91a2ea</gtr:id><gtr:otherNames>Povilonis J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>585d5a84547d29.88227768</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14B9998C-E574-4900-A3A9-ED6C18F75937</gtr:id><gtr:title>Genome Sequence of Klebsiella pneumoniae Ecl8, a Reference Strain for Targeted Genetic Manipulation.</gtr:title><gtr:parentPublicationTitle>Genome announcements</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8680b1bfc3c00951516c0e31c4692c3"><gtr:id>a8680b1bfc3c00951516c0e31c4692c3</gtr:id><gtr:otherNames>Fookes M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>FnS8AEL2CPt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37240017-85E9-4C8D-B946-BBB55453D592</gtr:id><gtr:title>Elucidating the regulon of multidrug resistance regulator RarA in Klebsiella pneumoniae.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df3614991a03102db4929c8541ca62c1"><gtr:id>df3614991a03102db4929c8541ca62c1</gtr:id><gtr:otherNames>De Majumdar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>Qad4y3mapNc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2456F2C3-DC89-40CA-BC82-5B4FF4E647DC</gtr:id><gtr:title>Elucidation of the RamA regulon in Klebsiella pneumoniae reveals a role in LPS regulation.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df3614991a03102db4929c8541ca62c1"><gtr:id>df3614991a03102db4929c8541ca62c1</gtr:id><gtr:otherNames>De Majumdar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>doi_55f984984159056b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A63320FB-0C5C-4A53-8170-58E36EAB8FBE</gtr:id><gtr:title>Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec5bfacf2a5bbffc593b18052f79366c"><gtr:id>ec5bfacf2a5bbffc593b18052f79366c</gtr:id><gtr:otherNames>Veleba M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>mhQT5fcHUHi</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601199</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>